Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2019 July;85(7) > Minerva Anestesiologica 2019 July;85(7):756-62



Opzioni di pubblicazione
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo


ORIGINAL ARTICLE   Free accessfree

Minerva Anestesiologica 2019 July;85(7):756-62

DOI: 10.23736/S0375-9393.19.13328-7


lingua: Inglese

LMA® Protector™ versus traditional LMA to perform endobronchial ultrasound-guided transbronchial needle aspiration: a retrospective analysis

Enzo ZAMPARELLI 1 , Alfonso FIORELLI 2, Giuseppe LA CERRA 1, Carmine GUARINO 1, Elena SANTORIELLO 3, Salvatore BUONO 4, Antonio CORCIONE 1, Marco RISPOLI 1

1 Unit of Anesthesiology and Intensive Care, Vincenzo Monaldi Hospital, Naples, Italy; 2 Unit of Thoracic Surgery, Luigi Vanvitelli University of Campania, Naples, Italy; 3 Unit of Anesthesiology and Intensive Care, Luigi Vanvitelli University of Campania, Naples, Italy; 4 Unit of Anesthesiology and Intensive Care, Hospital of Orthopedics and Traumatology, Naples, Italy

BACKGROUND: The aim of this study was to evaluate the use of laryngeal mask airway (LMA)® Protector™ by comparison with traditional LMA for performing endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA).
METHODS: This was a retrospective observational single-center study including 143 patients who underwent EBUS-TBNA for mediastinal staging of lung cancer. Patients were retrospectively divided into two groups based on whether a traditional LMA (traditional LMA group) or LMA Protector was used. Anesthesiologist outcomes, diagnostic yield of EBUS-TBNA, and complications related to the procedure were computed for each group and statistically compared.
RESULTS: LMA traditional group and LMA Protector group counted 70 and 73 patients, respectively. LMA traditional group versus LMA Protector group showed no significant difference on time of LMA insertion (120±25 vs. 118±39 s; P=0.49), reposition rates (18% vs. 16%; P=0.78); systolic pressure (140±55 vs. 118±37 mmHg; P=0.59); diastolic pressure (82±15 vs. 90±26 mmHg; P=0.39); heart rate (82±9.9 vs. 83±20 bpm; P=0.49); SpO2 values (93±21% vs. 92±14%; P=0.63); diagnostic accuracy (91.3% vs. 92%; P=0.95), and patients’ complications as nausea (4% vs. 3%; P=0.61); vomiting (3% vs. 1%, P=0.96); gastric aspiration (7% vs. 1%; P=0.08); and sore throat (7% vs. 3%; P=0.22). Conversely, LMA traditional group versus LMA Protector group presented a longer procedural time (47±23 vs. 38±17 s; P=0.02), higher number of passage to biopsy target lesion (4±0.5 vs. 3.1±0.6; P=0.01); higher rate of balloon ultrasound rupture (11% vs. 1%; P=0.01).
CONCLUSIONS: EBUS-TBNA conducted with LMA Protector is a useful strategy that reduced the procedural time and in theory ensured the comfort of patients. Our results should be confirmed by larger, prospective, randomized studies.

KEY WORDS: Laryngeal masks; Deep sedation; Bronchoscopy

inizio pagina